Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

4 results
Display

Thrombotic thrombocytopenic purpura-like syndrome associated with systemic lupus erythematosus: combined treatment with plasmapheresis and fresh frozen plasma infusion

Lim GT, Kim SS, Park SH, Choo WO, Kang DH, Park IS, Chang YS, Yoon YS, Bang BK

We report on a patient with systemic lupus erythematosus, who, during the course of the illness, developed thrombotic thrombocytopenic purpura. In this case, the coexistence of these two conditions...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful Treatment of Pure Red Cell Aplasia with Plasmapheresis in a Patient with Systemic Lupus Erythematosus

Choi BG, Yoo WH

Pure red cell aplasia (PRCA) is a rare cause of anemia associated with systemic lupus erythematosus (SLE), and fewer than 20 cases have been reported. The development of PRCA may...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Investigation of the Prevalence of Human Parvovirus B19 DNA in Korean Plasmapheresis Donors

Oh DJ, Lee YL, Kang JW, Kwon SY, Cho NS

BACKGROUND: To ensure the safety of plasma derivatives, some countries have been screening for the human parvovirus B19 (B19V) antigen or DNA in blood donors. We investigated the prevalence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients

Park HS, Hong Y, Sun IO, Chung BH, Kim HW, Choi BS, Park CW, Jin DC, Kim YS, Yang CW

  • KMID: 2070112
  • Korean J Intern Med.
  • 2014 Jul;29(4):482-488.
BACKGROUND/AIMS: Recurrent focal segmental glomerulosclerosis (FSGS) following renal transplantation is relatively common. However, the risk factors and optimal pretransplant treatment preventing recurrence of FSGS remain controversial. METHODS: We retrospectively reviewed 27...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr